The effectiveness and safety profile of netarsudil 0.02% in glaucoma treatment: real-world 6-month outcomes.
Graefes Arch Clin Exp Ophthalmol
; 260(3): 967-974, 2022 Mar.
Article
in En
| MEDLINE
| ID: mdl-34550421
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Glaucoma
/
Glaucoma, Open-Angle
/
Ocular Hypertension
Type of study:
Observational_studies
Limits:
Aged
/
Aged80
/
Humans
/
Middle aged
Language:
En
Journal:
Graefes Arch Clin Exp Ophthalmol
Year:
2022
Document type:
Article
Affiliation country:
United States
Country of publication:
Germany